Dr. Michael Seidman is Participating in a New Study to Test Treatment for Blast-induced Tinnitus.

Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt sleep and concentration, negatively impacting daily quality of life and mental health. There is currently no cure.

That is why the AdventHealth Research Institute is excited to be participating in a new multi-site clinical trial funded by the U.S. Department of Defense. Under the leadership of Principal Investigator Michael Seidman, MD, this study will evaluate the efficacy of etanercept, a TNF-alpha blocker, as a potential treatment for blast-induced tinnitus. Click the button below to learn more.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Understanding Hypoglycemia and the CLEAR Study

The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...

News

Did you know? Women, Hormones, and Heart Risk

Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...